Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
Recruiting
Observational Study
HCC - Hepatocellular Carcinoma
Cholangiocarcinoma Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,300 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer.
Intra arterial therapies are radiologic procedures that block liver cancer blood supply.
The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Os…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments:
* Trans-arterial embolization (TAE),
* Transarterial chemoembolization (TACE),
* Transarter…
Contacts